Joel M Reid Selected Research

Fatigue

1/2018	A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.
4/2015	A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report.
4/2014	A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors.
8/2011	Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.
6/2005	A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel M Reid Research Topics

Disease

99	Neoplasms (Cancer) 04/2024 - 02/2002
14	Breast Neoplasms (Breast Cancer) 12/2023 - 12/2008
10	Neutropenia 01/2018 - 02/2002
8	Neuroblastoma 01/2023 - 07/2006
8	Glioma (Gliomas) 10/2022 - 05/2003
8	Thrombocytopenia (Thrombopenia) 04/2015 - 09/2005
7	Leukemia 01/2019 - 09/2005
6	Ewing Sarcoma (Sarcoma, Ewing) 10/2023 - 01/2012
6	Nausea 12/2020 - 06/2005
5	Melanoma (Melanoma, Malignant) 04/2024 - 02/2004
5	Central Nervous System Neoplasms 01/2024 - 03/2007
5	Lymphoma (Lymphomas) 11/2023 - 09/2011
5	Vomiting 12/2020 - 06/2005
5	Diarrhea 01/2018 - 06/2005
5	Fatigue 01/2018 - 06/2005
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 08/2008
3	Rhabdomyosarcoma 01/2023 - 12/2020
3	Dehydration (Water Stress) 01/2020 - 08/2005
3	Hypertension (High Blood Pressure) 12/2018 - 10/2008
3	Pain (Aches) 01/2018 - 01/2016
3	Glioblastoma (Glioblastoma Multiforme) 05/2016 - 04/2009
3	Anorexia 03/2013 - 04/2010
2	Osteosarcoma (Osteogenic Sarcoma) 03/2024 - 11/2019
2	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 10/2012
2	Brain Neoplasms (Brain Tumor) 11/2023 - 11/2012
2	Disease Progression 11/2023 - 10/2022
2	Aggressive Fibromatosis (Desmoid) 12/2021 - 02/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2021 - 04/2008
2	Proteinuria 01/2018 - 08/2013
2	Low Back Pain (Lumbago) 01/2018 - 01/2016
2	Mucositis 01/2018 - 09/2005
2	Endometrial Neoplasms (Endometrial Cancer) 10/2017 - 12/2014
2	Hemorrhagic Cystitis 06/2016 - 06/2015
2	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 07/2015

Drug/Important Bio-Agent (IBA)

12	4-hydroxy-N-desmethyltamoxifenIBA 12/2023 - 12/2014
10	Tamoxifen FDA LinkGeneric 04/2023 - 12/2014
10	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 05/2003
10	Vorinostat FDA Link 01/2018 - 04/2009
8	Gemcitabine FDA Link 04/2024 - 01/2003
8	Estrogen ReceptorsIBA 04/2023 - 03/2015
8	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 05/2003
7	EnzymesIBA 03/2024 - 10/2005
7	Carboplatin (JM8)FDA LinkGeneric 02/2007 - 08/2002
5	Topotecan (Hycamtin)FDA LinkGeneric 01/2018 - 02/2002
4	Antineoplastic Agents (Antineoplastics)IBA 04/2024 - 07/2002
4	Bevacizumab (Avastin)FDA Link 03/2024 - 01/2008
4	Phosphotransferases (Kinase)IBA 01/2024 - 12/2018
4	Monoclonal AntibodiesIBA 10/2023 - 08/2008
4	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2023 - 12/2014
4	SteroidsIBA 01/2018 - 04/2009
4	Transaminases (Aminotransferases)IBA 01/2018 - 06/2005
4	Bortezomib (Velcade)FDA Link 04/2014 - 02/2007
4	alvocidib (flavopiridol)IBA 04/2013 - 08/2005
4	Proteins (Proteins, Gene)FDA Link 11/2011 - 07/2003
3	adavosertibIBA 01/2023 - 01/2020
3	Alanine Transaminase (SGPT)IBA 12/2020 - 04/2015
3	MLN 8237IBA 01/2019 - 04/2016
3	Lipase (Acid Lipase)FDA Link 12/2018 - 08/2013
3	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2018 - 01/2016
3	veliparibIBA 01/2018 - 09/2011
3	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 07/2002
3	Anticonvulsants (Antiepileptic Drugs)IBA 11/2015 - 10/2005
3	cixutumumabIBA 04/2015 - 01/2012
3	tanespimycin (17AAG)IBA 11/2011 - 03/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2008 - 03/2005
3	Pemetrexed (MTA)FDA Link 04/2007 - 06/2005
3	NSC 366140 (pyrazoloacridine)IBA 10/2005 - 08/2002
3	Cisplatin (Platino)FDA LinkGeneric 08/2005 - 02/2002
2	130-nm albumin-bound paclitaxelIBA 03/2024 - 01/2020
2	Immunoconjugates (Immunoconjugate)IBA 03/2024 - 11/2019
2	PlatinumIBA 03/2024 - 02/2007
2	Insulin (Novolin)FDA Link 10/2023 - 03/2015
2	NivolumabIBA 12/2022 - 01/2020
2	IpilimumabIBA 12/2022 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022 - 01/2022
2	AZD 6244IBA 10/2022 - 01/2022
2	Cystatin CIBA 01/2022 - 01/2019
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022 - 12/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2016
2	Hormones (Hormone)IBA 12/2021 - 02/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2016
2	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 04/2010
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2020 - 04/2008
2	Aromatase InhibitorsIBA 01/2020 - 01/2019
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2019 - 07/2002
2	Immunoglobulin G (IgG)IBA 01/2018 - 01/2016
2	BilirubinIBA 01/2018 - 07/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2010
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 09/2011
2	batracylinIBA 06/2016 - 06/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2016 - 02/2002
2	CreatinineIBA 10/2015 - 04/2013
2	epratuzumabIBA 07/2015 - 08/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2015 - 10/2010
2	temsirolimus FDA Link 04/2015 - 10/2012

Therapy/Procedure

20	Therapeutics 03/2024 - 05/2003
11	Drug Therapy (Chemotherapy) 04/2024 - 06/2003
4	Radiotherapy 11/2012 - 05/2003
3	Injections 01/2018 - 01/2016
2	Oral Administration 06/2015 - 01/2008